Vericel (VCEL) Gross Margin (2011 - 2026)

Vericel (VCEL) reported Gross Margin of 72.0% for Q1 2026, up 304.0% on a YoY basis from 17.82% in Q1 2025, and down 8.52% sequentially from 78.7% in Q4 2025.

Vericel (VCEL) Gross Margin (2011 - 2026) Analysis & Trends

Vericel (VCEL) has 16 years of Gross Margin data on file, last reported at 72.0% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin rose 304.0% year-over-year to 72.0%; the trailing twelve-month figure through Mar 2026 stood at 74.84% (up 230.0% YoY), and the FY2025 full-year result was 74.42%, up 187.0% from the prior year.
  • Gross Margin eased to 72.0% in Q1 2026, from 78.7% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 78.7% in Q4 2025 to a low of 62.06% in Q2 2022.
  • A 5-year average of 70.14% and a median of 69.5% in 2024 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin sank 603 bps in 2022 and soared 478 bps in 2024, its largest moves.
  • Tracing VCEL's Gross Margin over 5 years: stood at 72.59% in 2022, then increased by 3 bps to 74.63% in 2023, then increased by 4 bps to 77.61% in 2024, then gained by 1 bps to 78.7% in 2025, then declined by 9 bps to 72.0% in 2026.
  • Business Quant data shows VCEL's Gross Margin at 72.0% in Q1 2026, 78.7% in Q4 2025, and 73.46% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn 72.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 72.00%
Dec 31, 2025 78.70%
Sep 30, 2025 73.46%
Jun 30, 2025 73.71%
Mar 31, 2025 68.96%
Dec 31, 2024 77.61%
Sep 30, 2024 71.93%
Jun 30, 2024 69.50%
Mar 31, 2024 68.94%
Dec 31, 2023 74.63%
Sep 30, 2023 67.15%
Jun 30, 2023 65.20%
Mar 31, 2023 64.66%
Dec 31, 2022 72.59%
Sep 30, 2022 65.84%
Jun 30, 2022 62.06%
Mar 31, 2022 65.41%
Dec 31, 2021 71.51%
Sep 30, 2021 65.54%
Jun 30, 2021 68.09%